IP Library Granted Patent US 9,309,347
Granted Patent B2
US 9,309,347 · App. 13/253,720 · Granted Apr 12, 2016

Bioresorbable thermoset polyester/urethane elastomers

Inventors: Danny Concagh (Medfield, MA); Chang Cheng You (Burlington, MA); Greg Zugates (Chelmsford, MA)
Assignee: Biomedical, Inc.
C08G18/4266A61F2/90A61L31/06A61L31/10A61L31/16C08G18/428C08G18/4269C08G18/4277C08G18/72C08G18/73C08G18/771C08G63/08C08G63/912
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,309,347
App. No.
13/253,720
Granted
Apr 12, 2016
Kind
B2
Abstract

Bioresorbable thermoset elastomers and methods of making the same are disclosed. In certain embodiments, the thermoset elastomers include soft segments comprising branched polyesters, and hard segments including urethane and/or urea. The thermoset elastomers are made in certain embodiments by curing a branched prepolymer with a cross-linking agent. In certain embodiments, the mechanical properties of the thermoset elastomers are tailored by selecting the average molecular weight of the prepolymer, or by tuning the ratio of prepolymer to the cross-linking agent during curing, or by selecting a cross-linking agent with specific chemical characteristics.

Claims (35)

1. A polymer prepared by the process comprising the steps of:

providing a branched polyester having at least three branches and having a glass transition temperature less than about 25° Centigrade, wherein the polyester has an average molecular weight (Mn) of at least 20,000 g/mol; and

at least partially crosslinking said polyester with a symmetrical isocyanate cross linker,

wherein said polymer is an elastomer.

2. The polymer of claim 1 , wherein the polyester is Poly(lactide-co-ε-caprolactone).

3. The polymer of claim 2 , wherein the isocyanate crosslinker is hexamethylene diisocyanate.

4. The polymer of claim 1 , wherein the polyester is Poly(glycolide-co-ε-caprolactone).

5. The polymer of claim 4 , wherein the isocyanate crosslinker is hexamethylene diisocyanate.

6. The polymer of claim 1 , wherein the polyester is provided in a ratio of between 8:1 and 20:1 wt/wt relative to the isocyanate crosslinker during the crosslinking step.

7. The polymer of claim 1 , wherein the isocyanate crosslinker is present in a ratio of between approximately 1:1 and 120:1 mol/mol relative to the polyester during the cross-linking step.

8. The polymer of claim 1 , wherein the polyester has four branches.

9. The polymer of claim 1 , wherein the isocyanate crosslinker comprises two or more isocyanate groups of equal reactivity.

10. The polymer of claim 1 , wherein the isocyanate crosslinker is chosen for its lack of steric hindrance.

11. A polymer prepared by the process comprising the steps of:

providing a branched prepolymer with an average molecular weight of between 33 kDa and 65 kDa, the prepolymer having at least three branches and having a glass transition temperature less than about 25° Centigrade; and

curing said polymer with an isocyanate crosslinker.

12. The polymer of claim 11 , wherein the prepolymer is a polyester.

13. The polymer of claim 11 , wherein the isocyanate crosslinker is symmetrical.

14. The polymer of claim 11 , wherein the prepolymer is Poly(lactide-co-ε-caprolactone.

15. The polymer of claim 14 , wherein the isocyanate crosslinker is hexamethylene diisocyanate.

16. The polymer of claim 11 , wherein the prepolymer is Poly(glycolide-co-ε-caprolactone.

17. The polymer of claim 16 , wherein the isocyanate crosslinker is hexamethylene diisocyanate.

18. The polymer of claim 11 , wherein the prepolymer is provided in a ratio of between 8:1 and 20:1 wt/wt relative to the isocyanate crosslinker during the curing step.

19. The polymer of claim 11 , wherein the curing step takes place at 100° C.

20. The polymer of claim 11 , wherein the curing step is performed over 16 hours.

21. The polymer of claim 11 , wherein the method further comprises the steps of:

dissolving the prepolymer and the isocyanate crosslinker in a solvent; and

removing the solvent by evaporation.

22. The polymer of claim 1 , wherein said polymer is a thermoset elastomer.

23. The polymer of claim 22 , wherein said polymer is a bioresorbable thermoset elastomer.

24. The polymer of claim 1 , wherein the polymer exhibits an elongation at break that ranges from 280% to 940%.

25. The polymer of claim 24 , wherein the polyester has an average molecular weight (Mn) of at least 30,000 g/mol.

26. The polymer of claim 1 , wherein the polyester has an average molecular weight (Mn) of at least 30,000 g/mol.

27. The polymer of claim 1 , wherein the polyester has an average molecular weight (Mn) ranging from 30,000 g/mol to 100,000 g/mol.

28. The polymer of claim 26 , wherein the polyester is Poly(lactide-co-ε-caprolactone) or Poly(glycolide-co-ε-caprolactone).

Assignments (4)
CHANGE OF NAME Recorded Jan 17, 2020
From: 480 BIOMEDICAL, INC.
To: LYRA THERAPEUTICS, INC.
Reel/Frame 051637/0116 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2012
From: CONCAGH, DANNY; YOU, CHANGCHENG; ZUGATES, GREG
To: 480 BIOMEDICAL, INC.
Reel/Frame 027843/0296 →
CHANGE OF NAME Recorded Feb 15, 2012
From: ARSENAL MEDICAL, INC.
To: ARSENAL VASCULAR, INC.
Reel/Frame 027705/0758 →
CHANGE OF NAME Recorded Feb 15, 2012
From: ARSENAL VASCULAR, INC.
To: 480 BIOMEDICAL, INC.
Reel/Frame 027705/0770 →
Continuity (5)
Continuation In Part 12783261 · May 19, 2010
Provisional Application 61179834 · May 20, 2009
Provisional Application 61227308 · Jul 21, 2009
Provisional Application 61251984 · Oct 15, 2009
Related Publication 20120142884A1 · Jun 7, 2012